A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma
Clinical trial NCT02594384 · COMPLETED
Trial details
- NCT number
- NCT02594384
- Sponsor
- OrphAI Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2020-03-09
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.